GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Ybx1
|
ENSRNOG00000023786 | Y box binding protein 1 |
Nfya
|
ENSRNOG00000012702 | nuclear transcription factor Y subunit alpha |
Nfyb
|
ENSRNOG00000010309 | nuclear transcription factor Y subunit beta |
Nfyc
|
ENSRNOG00000010735 | nuclear transcription factor Y subunit gamma |
Cebpz
|
ENSRNOG00000005087 | CCAAT/enhancer binding protein zeta |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Nfya | rn6_v1_chr9_+_14551758_14551758 | 0.49 | 7.6e-21 | Click! |
Cebpz | rn6_v1_chr6_-_1534488_1534488 | 0.39 | 6.9e-13 | Click! |
Nfyc | rn6_v1_chr5_-_139748489_139748489 | 0.22 | 9.1e-05 | Click! |
Nfyb | rn6_v1_chr7_+_27089278_27089278 | 0.22 | 1.0e-04 | Click! |
Ybx1 | rn6_v1_chr5_-_138336475_138336475 | 0.15 | 5.7e-03 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr17_+_43423111 | 272.02 |
ENSRNOT00000022630
|
Hist1h2ba
|
histone cluster 1 H2B family member a |
chr17_-_43422846 | 258.55 |
ENSRNOT00000050526
|
Hist1h2aa
|
histone cluster 1 H2A family member a |
chr4_+_157348020 | 249.01 |
ENSRNOT00000020803
|
Cdca3
|
cell division cycle associated 3 |
chr2_-_112831476 | 240.97 |
ENSRNOT00000018055
|
Ect2
|
epithelial cell transforming 2 |
chr19_+_25077918 | 218.77 |
ENSRNOT00000006964
|
Asf1b
|
anti-silencing function 1B histone chaperone |
chr10_-_74413745 | 198.03 |
ENSRNOT00000038296
|
Prr11
|
proline rich 11 |
chr10_-_86932154 | 187.53 |
ENSRNOT00000085344
|
Top2a
|
topoisomerase (DNA) II alpha |
chr13_+_56546021 | 186.28 |
ENSRNOT00000016797
|
Aspm
|
abnormal spindle microtubule assembly |
chr16_-_36080191 | 181.93 |
ENSRNOT00000017635
|
Hmgb2l1
|
high mobility group box 2-like 1 |
chr8_+_48665652 | 156.21 |
ENSRNOT00000059715
|
H2afx
|
H2A histone family, member X |
chr15_+_23553128 | 142.43 |
ENSRNOT00000012985
|
Cdkn3
|
cyclin-dependent kinase inhibitor 3 |
chr13_+_110511668 | 137.92 |
ENSRNOT00000006235
|
Nek2
|
NIMA-related kinase 2 |
chr3_+_111422267 | 136.70 |
ENSRNOT00000052312
|
Nusap1
|
nucleolar and spindle associated protein 1 |
chr17_-_43627629 | 136.57 |
ENSRNOT00000022965
|
Hist1h2af
|
histone cluster 1, H2af |
chr13_-_108178609 | 134.89 |
ENSRNOT00000004525
|
Cenpf
|
centromere protein F |
chr3_-_120404910 | 130.59 |
ENSRNOT00000051783
|
Bub1
|
BUB1 mitotic checkpoint serine/threonine kinase |
chr17_-_13593423 | 128.93 |
ENSRNOT00000019234
|
Cks2
|
CDC28 protein kinase regulatory subunit 2 |
chr8_+_91368430 | 123.40 |
ENSRNOT00000051612
|
Ttk
|
Ttk protein kinase |
chr3_-_111422203 | 123.06 |
ENSRNOT00000084290
|
Oip5
|
Opa interacting protein 5 |
chr17_+_43627930 | 123.04 |
ENSRNOT00000081719
|
LOC102549061
|
histone H2B type 1-N-like |
chr6_-_27080856 | 120.14 |
ENSRNOT00000012512
|
Cenpa
|
centromere protein A |
chr10_-_13619935 | 118.63 |
ENSRNOT00000064392
|
Ccnf
|
cyclin F |
chr10_-_91027465 | 116.38 |
ENSRNOT00000032339
|
Kif18b
|
kinesin family member 18B |
chr10_-_91027731 | 115.13 |
ENSRNOT00000084128
ENSRNOT00000093704 |
Kif18b
|
kinesin family member 18B |
chr10_-_25890639 | 113.96 |
ENSRNOT00000085499
|
Hmmr
|
hyaluronan-mediated motility receptor |
chr2_+_198388809 | 111.25 |
ENSRNOT00000083087
|
Hist2h2aa3
|
histone cluster 2, H2aa3 |
chr2_-_198382190 | 109.74 |
ENSRNOT00000044268
|
Hist2h2aa2
|
histone cluster 2, H2aa2 |
chr8_+_91368111 | 109.47 |
ENSRNOT00000083151
|
Ttk
|
Ttk protein kinase |
chr1_+_141391262 | 104.73 |
ENSRNOT00000031783
|
Ticrr
|
TOPBP1-interacting checkpoint and replication regulator |
chr8_+_71514281 | 100.31 |
ENSRNOT00000022256
|
Ns5atp9
|
NS5A (hepatitis C virus) transactivated protein 9 |
chr17_+_43633675 | 100.16 |
ENSRNOT00000072119
|
LOC102549173
|
histone H3.2-like |
chr5_-_142933526 | 95.96 |
ENSRNOT00000048293
|
Cdca8
|
cell division cycle associated 8 |
chr20_+_20576377 | 93.99 |
ENSRNOT00000000783
ENSRNOT00000086806 |
Cdk1
|
cyclin-dependent kinase 1 |
chr10_-_45297385 | 93.03 |
ENSRNOT00000041187
|
Hist3h2bb
|
histone cluster 3 H2B family member b |
chr17_+_44528125 | 91.85 |
ENSRNOT00000084538
|
LOC680322
|
similar to Histone H2A type 1 |
chr17_-_44758170 | 90.50 |
ENSRNOT00000091176
|
Hist1h2bo
|
histone cluster 1 H2B family member o |
chr3_-_91217491 | 86.28 |
ENSRNOT00000006115
|
Rag1
|
recombination activating 1 |
chr2_+_198359754 | 85.77 |
ENSRNOT00000048582
|
Hist2h2ab
|
histone cluster 2 H2A family member b |
chr17_-_44748188 | 85.76 |
ENSRNOT00000081970
|
LOC103690190
|
histone H2A type 1-E |
chr15_+_83442144 | 85.12 |
ENSRNOT00000039344
|
Bora
|
bora, aurora kinase A activator |
chr15_-_44411004 | 85.04 |
ENSRNOT00000031163
|
Cdca2
|
cell division cycle associated 2 |
chr10_+_45289741 | 84.42 |
ENSRNOT00000066190
|
Hist3h2ba
|
histone cluster 3, H2ba |
chr5_-_137265015 | 83.75 |
ENSRNOT00000036151
|
Cdc20
|
cell division cycle 20 |
chr17_+_43616247 | 82.00 |
ENSRNOT00000072019
|
Hist1h3a
|
histone cluster 1, H3a |
chr10_+_55626741 | 80.36 |
ENSRNOT00000008492
|
Aurkb
|
aurora kinase B |
chr2_-_30791221 | 80.23 |
ENSRNOT00000082846
|
Ccnb1
|
cyclin B1 |
chr2_+_198390166 | 79.55 |
ENSRNOT00000081042
|
Hist2h3c2
|
histone cluster 2, H3c2 |
chr7_+_140758615 | 77.29 |
ENSRNOT00000089448
|
Troap
|
trophinin associated protein |
chr10_-_29026002 | 76.75 |
ENSRNOT00000005070
|
Pttg1
|
pituitary tumor-transforming 1 |
chr3_+_148327965 | 73.98 |
ENSRNOT00000010851
ENSRNOT00000088481 |
Tpx2
|
TPX2, microtubule nucleation factor |
chr17_-_44840131 | 73.82 |
ENSRNOT00000083417
|
Hist1h3b
|
histone cluster 1, H3b |
chr3_+_2591331 | 72.75 |
ENSRNOT00000017466
|
Sapcd2
|
suppressor APC domain containing 2 |
chr3_+_161236898 | 72.68 |
ENSRNOT00000082303
ENSRNOT00000020323 |
Ube2c
|
ubiquitin-conjugating enzyme E2C |
chr1_+_256035866 | 72.12 |
ENSRNOT00000079726
|
Kif11
|
kinesin family member 11 |
chr3_-_121822436 | 71.95 |
ENSRNOT00000039794
|
Ckap2l
|
cytoskeleton associated protein 2-like |
chr17_+_44520537 | 71.70 |
ENSRNOT00000077985
|
hist1h2ail2
|
histone cluster 1, H2ai-like2 |
chr12_-_22138382 | 71.69 |
ENSRNOT00000001899
|
Lrch4
|
leucine rich repeats and calponin homology domain containing 4 |
chr17_-_44527801 | 71.14 |
ENSRNOT00000089643
|
Hist1h2bk
|
histone cluster 1 H2B family member k |
chr18_+_27424328 | 69.83 |
ENSRNOT00000033784
|
Kif20a
|
kinesin family member 20A |
chr17_-_43614844 | 69.27 |
ENSRNOT00000023054
|
Hist1h1a
|
histone cluster 1 H1 family member a |
chr17_+_42302540 | 67.96 |
ENSRNOT00000025389
|
Gmnn
|
geminin, DNA replication inhibitor |
chr19_-_10360310 | 67.91 |
ENSRNOT00000087100
|
Katnb1
|
katanin regulatory subunit B1 |
chr17_-_43776460 | 67.82 |
ENSRNOT00000089055
|
Hist2h3c2
|
histone cluster 2, H3c2 |
chr2_+_198418691 | 67.53 |
ENSRNOT00000089409
|
Hist1h2bk
|
histone cluster 1, H2bk |
chr17_+_44758460 | 66.92 |
ENSRNOT00000089436
|
Hist1h2an
|
histone cluster 1, H2an |
chr15_-_42518855 | 66.73 |
ENSRNOT00000076451
|
Esco2
|
establishment of sister chromatid cohesion N-acetyltransferase 2 |
chr4_-_118472179 | 65.96 |
ENSRNOT00000023856
|
Mxd1
|
max dimerization protein 1 |
chr15_+_34296922 | 65.70 |
ENSRNOT00000026430
|
Rec8
|
REC8 meiotic recombination protein |
chr9_-_10757954 | 64.71 |
ENSRNOT00000075265
|
Uhrf1
|
ubiquitin-like with PHD and ring finger domains 1 |
chr2_-_198360678 | 64.56 |
ENSRNOT00000051917
|
Hist2h2ac
|
histone cluster 2 H2A family member c |
chr9_-_10757720 | 64.00 |
ENSRNOT00000083848
|
Uhrf1
|
ubiquitin-like with PHD and ring finger domains 1 |
chr5_-_57845509 | 63.64 |
ENSRNOT00000035541
|
Kif24
|
kinesin family member 24 |
chr2_-_198380836 | 63.45 |
ENSRNOT00000040906
|
LOC102548682
|
histone H4-like |
chr17_+_43632397 | 63.19 |
ENSRNOT00000013790
|
Hist1h2ah
|
histone cluster 1, H2ah |
chr2_+_34312766 | 62.75 |
ENSRNOT00000060962
|
Cenpk
|
centromere protein K |
chr17_+_44748482 | 62.69 |
ENSRNOT00000083765
|
Hist1h2bl
|
histone cluster 1 H2B family member l |
chr1_+_192115966 | 62.49 |
ENSRNOT00000025629
|
Plk1
|
polo-like kinase 1 |
chr17_+_44794130 | 62.39 |
ENSRNOT00000077571
|
Hist1h2ac
|
histone cluster 1, H2ac |
chr17_-_43815183 | 62.17 |
ENSRNOT00000073188
|
Hist1h2ail1
|
histone cluster 1, H2ai-like1 |
chr10_+_56546710 | 62.06 |
ENSRNOT00000023003
|
Ybx2
|
Y box binding protein 2 |
chr2_-_123282214 | 61.84 |
ENSRNOT00000021156
|
Ccna2
|
cyclin A2 |
chr7_-_141307233 | 61.83 |
ENSRNOT00000071885
|
Racgap1
|
Rac GTPase-activating protein 1 |
chr9_+_64898459 | 61.56 |
ENSRNOT00000029526
|
Sgo2
|
shugoshin 2 |
chr17_+_44738643 | 61.29 |
ENSRNOT00000087643
|
LOC100910554
|
histone H2A type 1-like |
chr17_-_44520240 | 60.94 |
ENSRNOT00000086538
|
Hist1h2bh
|
histone cluster 1 H2B family member h |
chr9_+_98279022 | 60.43 |
ENSRNOT00000038536
|
Rbm44
|
RNA binding motif protein 44 |
chr17_+_43791657 | 60.37 |
ENSRNOT00000074024
|
Hist2h3c2
|
histone cluster 2, H3c2 |
chr17_-_43626538 | 59.97 |
ENSRNOT00000074292
|
Hist2h3c2
|
histone cluster 2, H3c2 |
chr20_+_5509059 | 59.60 |
ENSRNOT00000065349
|
Kifc1
|
kinesin family member C1 |
chr17_-_43798383 | 59.35 |
ENSRNOT00000075069
|
LOC684828
|
similar to Histone H1.2 (H1 VAR.1) (H1c) |
chr12_-_46494174 | 59.14 |
ENSRNOT00000086716
|
Cit
|
citron rho-interacting serine/threonine kinase |
chr1_-_265798167 | 58.63 |
ENSRNOT00000079483
|
Ldb1
|
LIM domain binding 1 |
chr10_+_74413989 | 57.40 |
ENSRNOT00000036098
|
Ska2
|
spindle and kinetochore associated complex subunit 2 |
chr4_-_157798868 | 57.30 |
ENSRNOT00000044425
|
Tuba3b
|
tubulin, alpha 3B |
chr3_-_46457201 | 56.80 |
ENSRNOT00000010683
|
Ly75
|
lymphocyte antigen 75 |
chr4_-_115015965 | 56.75 |
ENSRNOT00000014603
|
Mthfd2
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase |
chr9_+_40972089 | 54.98 |
ENSRNOT00000067928
|
Ptpn18
|
protein tyrosine phosphatase, non-receptor type 18 |
chr10_+_29289203 | 54.92 |
ENSRNOT00000067013
|
Pwwp2a
|
PWWP domain containing 2A |
chr1_+_91663736 | 54.59 |
ENSRNOT00000089587
ENSRNOT00000031236 |
Cep89
|
centrosomal protein 89 |
chr2_-_123281856 | 54.51 |
ENSRNOT00000079745
|
Ccna2
|
cyclin A2 |
chr1_+_178039063 | 54.40 |
ENSRNOT00000046313
|
Arntl
|
aryl hydrocarbon receptor nuclear translocator-like |
chr17_+_44760056 | 54.30 |
ENSRNOT00000052073
|
LOC690171
|
similar to H3 histone, family 3B |
chr3_-_119611136 | 53.03 |
ENSRNOT00000016157
|
Ncaph
|
non-SMC condensin I complex, subunit H |
chr17_-_43807540 | 52.89 |
ENSRNOT00000074763
|
LOC684762
|
similar to CG31613-PA |
chr2_+_264704769 | 52.87 |
ENSRNOT00000012667
|
Depdc1
|
DEP domain containing 1 |
chr12_+_38880377 | 52.48 |
ENSRNOT00000064390
|
Rhof
|
ras homolog family member F, filopodia associated |
chr3_-_124884570 | 52.40 |
ENSRNOT00000028887
|
Pcna
|
proliferating cell nuclear antigen |
chr13_-_84452181 | 51.25 |
ENSRNOT00000005060
|
Mael
|
maelstrom spermatogenic transposon silencer |
chr10_-_85124644 | 50.81 |
ENSRNOT00000012376
|
Kpnb1
|
karyopherin subunit beta 1 |
chr9_-_26932201 | 49.71 |
ENSRNOT00000017081
|
Mcm3
|
minichromosome maintenance complex component 3 |
chr1_-_88734223 | 49.28 |
ENSRNOT00000065011
|
NEWGENE_1306714
|
WD repeat domain 62-like 1 |
chr17_-_44793927 | 48.62 |
ENSRNOT00000086309
|
Hist1h2bo
|
histone cluster 1 H2B family member o |
chr17_-_44841382 | 48.25 |
ENSRNOT00000080119
|
Hist1h2ak
|
histone cluster 1, H2ak |
chr20_+_3875706 | 47.00 |
ENSRNOT00000036900
|
RT1-Ha
|
RT1 class II, locus Ha |
chr2_-_188745144 | 46.70 |
ENSRNOT00000055533
|
Cks1b
|
CDC28 protein kinase regulatory subunit 1B |
chr3_+_100366168 | 46.57 |
ENSRNOT00000006689
|
Kif18a
|
kinesin family member 18A |
chr2_+_252263386 | 46.52 |
ENSRNOT00000092913
ENSRNOT00000084034 ENSRNOT00000041186 ENSRNOT00000092931 |
Ssx2ip
|
SSX family member 2 interacting protein |
chr17_+_44766313 | 45.97 |
ENSRNOT00000091688
|
Hist1h1b
|
histone cluster 1 H1 family member b |
chr1_-_42467586 | 45.68 |
ENSRNOT00000029416
|
Fbxo5
|
F-box protein 5 |
chr6_-_123894826 | 45.40 |
ENSRNOT00000082444
|
Efcab11
|
EF-hand calcium binding domain 11 |
chr7_+_53275676 | 44.73 |
ENSRNOT00000031986
|
E2f7
|
E2F transcription factor 7 |
chr1_-_187779675 | 44.68 |
ENSRNOT00000024648
|
Arl6ip1
|
ADP-ribosylation factor like GTPase 6 interacting protein 1 |
chr10_-_95212111 | 44.57 |
ENSRNOT00000020795
|
Kpna2
|
karyopherin subunit alpha 2 |
chr1_-_198476476 | 44.56 |
ENSRNOT00000027525
|
Kif22
|
kinesin family member 22 |
chr4_+_161685258 | 44.21 |
ENSRNOT00000008012
ENSRNOT00000008003 |
Foxm1
|
forkhead box M1 |
chr12_-_38274036 | 44.18 |
ENSRNOT00000063990
|
Kntc1
|
kinetochore associated 1 |
chr18_+_36829062 | 44.11 |
ENSRNOT00000025467
ENSRNOT00000086979 |
Tcerg1
|
transcription elongation regulator 1 |
chr17_+_43673294 | 44.05 |
ENSRNOT00000074109
|
Hist2h4a
|
histone cluster 2, H4 |
chr1_-_225952516 | 43.69 |
ENSRNOT00000043387
|
Incenp
|
inner centromere protein |
chr6_+_43884678 | 43.53 |
ENSRNOT00000091551
|
Rrm2
|
ribonucleotide reductase regulatory subunit M2 |
chr1_-_81534140 | 42.98 |
ENSRNOT00000027202
|
Tex101
|
testis expressed 101 |
chr7_-_12246729 | 42.81 |
ENSRNOT00000044030
|
Reep6
|
receptor accessory protein 6 |
chr4_+_148199102 | 42.72 |
ENSRNOT00000083563
|
Zfand4
|
zinc finger AN1-type containing 4 |
chr10_-_15282951 | 41.22 |
ENSRNOT00000027266
|
Rab40c
|
Rab40c, member RAS oncogene family |
chr7_+_126736732 | 41.19 |
ENSRNOT00000022012
|
Gtse1
|
G-2 and S-phase expressed 1 |
chr14_+_10692764 | 41.13 |
ENSRNOT00000003012
|
LOC100910270
|
uncharacterized LOC100910270 |
chr7_+_143897014 | 41.00 |
ENSRNOT00000017314
|
Espl1
|
extra spindle pole bodies like 1, separase |
chr3_+_111422435 | 40.87 |
ENSRNOT00000081934
|
Nusap1
|
nucleolar and spindle associated protein 1 |
chr8_+_79054237 | 40.84 |
ENSRNOT00000077613
|
Mns1
|
meiosis-specific nuclear structural 1 |
chr1_+_178351680 | 40.72 |
ENSRNOT00000018532
ENSRNOT00000076925 ENSRNOT00000076430 ENSRNOT00000076756 |
Far1
|
fatty acyl CoA reductase 1 |
chr7_-_120295618 | 40.43 |
ENSRNOT00000014413
|
Ankrd54
|
ankyrin repeat domain 54 |
chr14_+_108007724 | 39.72 |
ENSRNOT00000014062
|
Xpo1
|
exportin 1 |
chr4_+_127164453 | 39.71 |
ENSRNOT00000017889
|
Kbtbd8
|
kelch repeat and BTB domain containing 8 |
chr4_+_34282625 | 39.42 |
ENSRNOT00000011138
ENSRNOT00000086735 |
Glcci1
|
glucocorticoid induced 1 |
chr4_+_145282797 | 39.41 |
ENSRNOT00000085766
|
Ogg1
|
8-oxoguanine DNA glycosylase |
chr16_+_74752655 | 39.40 |
ENSRNOT00000029266
|
Ckap2
|
cytoskeleton associated protein 2 |
chr1_-_91663467 | 39.36 |
ENSRNOT00000033396
|
Faap24
|
Fanconi anemia core complex associated protein 24 |
chr10_-_65820538 | 39.29 |
ENSRNOT00000011808
|
Tmem97
|
transmembrane protein 97 |
chr5_-_153924896 | 39.22 |
ENSRNOT00000065247
|
Grhl3
|
grainyhead-like transcription factor 3 |
chr8_+_48382121 | 39.18 |
ENSRNOT00000008685
|
Thy1
|
Thy-1 cell surface antigen |
chrX_-_72034099 | 38.63 |
ENSRNOT00000004310
|
Ercc6l
|
ERCC excision repair 6 like, spindle assembly checkpoint helicase |
chr20_-_3419831 | 38.62 |
ENSRNOT00000046798
|
Mdc1
|
mediator of DNA damage checkpoint 1 |
chr17_-_1672021 | 38.40 |
ENSRNOT00000036287
|
Zfp367
|
zinc finger protein 367 |
chr11_+_88122271 | 38.39 |
ENSRNOT00000002540
|
Sdf2l1
|
stromal cell-derived factor 2-like 1 |
chr17_-_44738330 | 38.37 |
ENSRNOT00000072195
|
LOC100364835
|
histone cluster 1, H2bd-like |
chr19_-_56126063 | 38.25 |
ENSRNOT00000022658
|
Fanca
|
Fanconi anemia, complementation group A |
chr10_+_103713045 | 38.03 |
ENSRNOT00000004351
|
Slc9a3r1
|
SLC9A3 regulator 1 |
chr5_-_169658875 | 37.95 |
ENSRNOT00000015840
|
Kcnab2
|
potassium voltage-gated channel subfamily A regulatory beta subunit 2 |
chr17_+_43734461 | 37.78 |
ENSRNOT00000072564
|
Hist1h1d
|
histone cluster 1, H1d |
chr5_-_147743723 | 37.58 |
ENSRNOT00000012854
|
Hdac1
|
histone deacetylase 1 |
chr4_+_179905116 | 37.56 |
ENSRNOT00000052352
|
Tuba3a
|
tubulin, alpha 3A |
chr5_-_164679654 | 37.42 |
ENSRNOT00000035695
|
LOC100911456
|
migration and invasion-inhibitory protein-like |
chr10_-_15098791 | 37.37 |
ENSRNOT00000026139
|
Chtf18
|
chromosome transmission fidelity factor 18 |
chr1_+_190914946 | 37.31 |
ENSRNOT00000039447
|
LOC691551
|
similar to F28B3.5a |
chr16_-_48921242 | 37.06 |
ENSRNOT00000041596
|
Cenpu
|
centromere protein U |
chr1_+_86996093 | 36.97 |
ENSRNOT00000027425
ENSRNOT00000027494 |
Hnrnpl
|
heterogeneous nuclear ribonucleoprotein L |
chr10_-_13515448 | 36.75 |
ENSRNOT00000067660
|
Pdpk1
|
3-phosphoinositide dependent protein kinase-1 |
chr1_-_214202853 | 36.62 |
ENSRNOT00000022954
|
Lmntd2
|
lamin tail domain containing 2 |
chr12_-_19314016 | 36.38 |
ENSRNOT00000001825
|
Mcm7
|
minichromosome maintenance complex component 7 |
chr5_+_24434872 | 35.88 |
ENSRNOT00000010696
|
Ccne2
|
cyclin E2 |
chr2_-_165641573 | 35.80 |
ENSRNOT00000013987
|
Trim59
|
tripartite motif-containing 59 |
chr20_+_12429315 | 35.73 |
ENSRNOT00000001675
|
Pcbp3
|
poly(rC) binding protein 3 |
chr19_-_52499433 | 35.69 |
ENSRNOT00000021954
|
Cotl1
|
coactosin-like F-actin binding protein 1 |
chr7_-_123476238 | 35.49 |
ENSRNOT00000036917
|
Cenpm
|
centromere protein M |
chr11_+_66878658 | 35.36 |
ENSRNOT00000003208
|
Eaf2
|
ELL associated factor 2 |
chr3_+_146695344 | 35.32 |
ENSRNOT00000010955
|
Gins1
|
GINS complex subunit 1 |
chr14_-_21219454 | 35.31 |
ENSRNOT00000049462
|
Enam
|
enamelin |
chr10_+_57040267 | 35.24 |
ENSRNOT00000026207
|
Arrb2
|
arrestin, beta 2 |
chr8_-_12355091 | 35.08 |
ENSRNOT00000009318
|
Cep57
|
centrosomal protein 57 |
chr10_-_62191512 | 35.01 |
ENSRNOT00000090262
|
Rpa1
|
replication protein A1 |
chr5_+_150957001 | 34.89 |
ENSRNOT00000017549
|
Rpa2
|
replication protein A2 |
chr4_+_157659147 | 34.87 |
ENSRNOT00000048379
|
Iffo1
|
intermediate filament family orphan 1 |
chr7_-_28715224 | 34.80 |
ENSRNOT00000065899
|
Parpbp
|
PARP1 binding protein |
chr19_-_27464805 | 34.74 |
ENSRNOT00000039467
|
Orc6
|
origin recognition complex, subunit 6 |
chr1_+_224939497 | 34.63 |
ENSRNOT00000025664
|
Stx5
|
syntaxin 5 |
chr1_+_72661211 | 34.60 |
ENSRNOT00000033197
|
Cox6b2
|
cytochrome c oxidase subunit VIb polypeptide 2 |
chr2_+_240396152 | 34.52 |
ENSRNOT00000034565
|
Cenpe
|
centromere protein E |
chr1_+_219078029 | 34.34 |
ENSRNOT00000023020
|
Chka
|
choline kinase alpha |
chr17_-_78812111 | 34.27 |
ENSRNOT00000021506
|
Dclre1c
|
DNA cross-link repair 1C |
chr5_+_117583502 | 34.05 |
ENSRNOT00000010933
|
Usp1
|
ubiquitin specific peptidase 1 |
chr2_+_198417619 | 34.04 |
ENSRNOT00000085945
|
Hist2h3c2
|
histone cluster 2, H3c2 |
chr17_+_44763598 | 34.03 |
ENSRNOT00000079880
|
Hist1h3b
|
histone cluster 1, H3b |
chr5_-_147761983 | 33.86 |
ENSRNOT00000012936
|
Lck
|
LCK proto-oncogene, Src family tyrosine kinase |
chr2_+_198360998 | 33.83 |
ENSRNOT00000046129
|
Hist2h2be
|
histone cluster 2, H2be |
chr15_+_33555640 | 33.46 |
ENSRNOT00000021096
|
Pabpn1
|
poly(A) binding protein, nuclear 1 |
chr4_+_69457472 | 33.43 |
ENSRNOT00000067597
|
Trbv19
|
T cell receptor beta, variable 19 |
chr14_-_6813945 | 33.21 |
ENSRNOT00000002938
|
Ibsp
|
integrin-binding sialoprotein |
chr13_+_52976507 | 33.13 |
ENSRNOT00000090599
ENSRNOT00000011324 |
Kif21b
|
kinesin family member 21B |
chr19_+_19395655 | 32.82 |
ENSRNOT00000019130
|
Snx20
|
sorting nexin 20 |
chr19_+_9668186 | 32.72 |
ENSRNOT00000016563
|
Cnot1
|
CCR4-NOT transcription complex, subunit 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
77.6 | 232.9 | GO:1902103 | metaphase/anaphase transition of meiotic cell cycle(GO:0044785) regulation of metaphase/anaphase transition of meiotic cell cycle(GO:1902102) negative regulation of metaphase/anaphase transition of meiotic cell cycle(GO:1902103) regulation of meiotic chromosome separation(GO:1905132) negative regulation of meiotic chromosome separation(GO:1905133) |
46.0 | 137.9 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
45.3 | 272.0 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
39.6 | 118.7 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
37.4 | 224.5 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
37.4 | 37.4 | GO:0051985 | negative regulation of chromosome segregation(GO:0051985) |
31.3 | 187.5 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
30.8 | 61.6 | GO:0070602 | regulation of centromeric sister chromatid cohesion(GO:0070602) |
30.6 | 183.9 | GO:0090166 | Golgi disassembly(GO:0090166) |
29.8 | 208.4 | GO:0000022 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
29.2 | 175.4 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
27.6 | 745.8 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
27.3 | 109.2 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
25.9 | 362.0 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
24.2 | 72.7 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
23.3 | 69.8 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
22.6 | 45.2 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
22.3 | 66.8 | GO:1903165 | response to polycyclic arene(GO:1903165) |
21.4 | 128.7 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
20.5 | 163.7 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
20.4 | 20.4 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
19.8 | 118.6 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
19.4 | 116.4 | GO:0071314 | cellular response to cocaine(GO:0071314) |
18.4 | 239.8 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
18.2 | 181.9 | GO:0006265 | DNA topological change(GO:0006265) |
17.9 | 71.6 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
17.5 | 69.9 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
16.7 | 66.7 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
16.6 | 1559.9 | GO:0006342 | chromatin silencing(GO:0006342) |
16.4 | 82.1 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
16.3 | 32.5 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
16.0 | 1087.4 | GO:0006334 | nucleosome assembly(GO:0006334) |
14.9 | 44.7 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
14.2 | 28.4 | GO:0032423 | regulation of mismatch repair(GO:0032423) |
14.0 | 14.0 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
13.1 | 39.2 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
13.1 | 65.3 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
13.0 | 168.5 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
12.8 | 12.8 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
12.6 | 75.9 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
12.5 | 37.5 | GO:0070175 | positive regulation of enamel mineralization(GO:0070175) |
12.0 | 120.1 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
12.0 | 12.0 | GO:1904815 | negative regulation of protein localization to chromosome, telomeric region(GO:1904815) |
11.8 | 141.1 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
11.2 | 67.4 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
11.1 | 22.2 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
11.1 | 55.4 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
11.0 | 32.9 | GO:1905073 | occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
10.9 | 492.5 | GO:0051310 | metaphase plate congression(GO:0051310) |
10.9 | 54.4 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
10.5 | 10.5 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
10.4 | 31.2 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
10.2 | 30.5 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
10.2 | 61.0 | GO:0002503 | MHC class II protein complex assembly(GO:0002399) peptide antigen assembly with MHC class II protein complex(GO:0002503) |
9.7 | 58.2 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
9.7 | 96.9 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
9.4 | 94.1 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
9.3 | 157.3 | GO:0034587 | piRNA metabolic process(GO:0034587) |
9.2 | 27.6 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
9.1 | 191.8 | GO:0006270 | DNA replication initiation(GO:0006270) |
8.6 | 51.4 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
8.5 | 25.6 | GO:1904760 | myofibroblast differentiation(GO:0036446) cardiac fibroblast cell differentiation(GO:0060935) cardiac fibroblast cell development(GO:0060936) epicardium-derived cardiac fibroblast cell differentiation(GO:0060938) epicardium-derived cardiac fibroblast cell development(GO:0060939) regulation of myofibroblast differentiation(GO:1904760) |
8.5 | 25.5 | GO:1901258 | sensory system development(GO:0048880) cardiac cell fate determination(GO:0060913) positive regulation of granulocyte colony-stimulating factor production(GO:0071657) positive regulation of macrophage colony-stimulating factor production(GO:1901258) |
8.3 | 33.1 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
8.2 | 57.6 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
8.2 | 32.6 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
8.0 | 32.1 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
8.0 | 80.0 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
7.9 | 23.8 | GO:0071245 | cellular response to carbon monoxide(GO:0071245) |
7.9 | 31.7 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
7.9 | 118.5 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
7.8 | 54.9 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
7.7 | 38.5 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
7.6 | 60.8 | GO:1902969 | mitotic DNA replication(GO:1902969) |
7.4 | 29.8 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
7.4 | 29.6 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
7.3 | 14.6 | GO:1900114 | positive regulation of histone H3-K9 trimethylation(GO:1900114) |
7.3 | 29.1 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
7.1 | 28.2 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
7.0 | 392.9 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
6.9 | 48.1 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
6.9 | 27.5 | GO:0038001 | paracrine signaling(GO:0038001) TNFSF11-mediated signaling pathway(GO:0071847) |
6.9 | 109.8 | GO:0006298 | mismatch repair(GO:0006298) |
6.7 | 20.0 | GO:0030578 | PML body organization(GO:0030578) |
6.6 | 26.5 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) |
6.6 | 19.9 | GO:2000978 | negative regulation of pro-B cell differentiation(GO:2000974) negative regulation of forebrain neuron differentiation(GO:2000978) |
6.6 | 19.8 | GO:0060066 | oviduct development(GO:0060066) |
6.5 | 13.1 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
6.5 | 19.4 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
6.4 | 70.7 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
6.4 | 25.7 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
6.4 | 19.2 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
6.4 | 50.9 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
6.4 | 19.1 | GO:1904380 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) endoplasmic reticulum mannose trimming(GO:1904380) |
6.2 | 18.7 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
6.2 | 37.0 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
5.9 | 17.8 | GO:1903936 | cellular response to sodium arsenite(GO:1903936) |
5.9 | 70.8 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
5.9 | 17.7 | GO:0098749 | cerebellar neuron development(GO:0098749) |
5.6 | 38.9 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
5.5 | 72.0 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
5.5 | 21.9 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
5.4 | 16.3 | GO:0033385 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
5.4 | 10.8 | GO:2000612 | thyroid-stimulating hormone secretion(GO:0070460) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
5.4 | 5.4 | GO:0007144 | female meiosis I(GO:0007144) |
5.3 | 31.7 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
5.3 | 21.0 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
5.3 | 84.1 | GO:0007141 | male meiosis I(GO:0007141) |
5.2 | 51.5 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
5.0 | 15.1 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
5.0 | 65.1 | GO:0043968 | histone H2A acetylation(GO:0043968) |
4.9 | 24.7 | GO:2000564 | regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
4.9 | 19.7 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
4.9 | 34.3 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
4.8 | 38.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
4.7 | 9.5 | GO:0019230 | proprioception(GO:0019230) |
4.7 | 19.0 | GO:1904528 | positive regulation of microtubule binding(GO:1904528) |
4.7 | 23.6 | GO:0007135 | meiosis II(GO:0007135) |
4.7 | 23.4 | GO:0072615 | interleukin-17 secretion(GO:0072615) |
4.7 | 18.7 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
4.6 | 13.9 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
4.6 | 13.8 | GO:2000410 | regulation of thymocyte migration(GO:2000410) |
4.6 | 13.7 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
4.5 | 40.5 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
4.5 | 13.5 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
4.4 | 13.3 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
4.4 | 13.3 | GO:0046952 | ketone body catabolic process(GO:0046952) |
4.4 | 22.0 | GO:0021747 | cochlear nucleus development(GO:0021747) |
4.4 | 8.8 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
4.4 | 65.8 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
4.3 | 25.7 | GO:0089700 | protein kinase D signaling(GO:0089700) |
4.3 | 21.4 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
4.3 | 12.8 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
4.3 | 17.0 | GO:0070494 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
4.2 | 12.7 | GO:0046490 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
4.2 | 8.3 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
4.1 | 24.9 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
4.1 | 40.9 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
3.9 | 27.5 | GO:0006868 | glutamine transport(GO:0006868) |
3.9 | 11.6 | GO:0014028 | notochord formation(GO:0014028) |
3.8 | 23.1 | GO:0071386 | cellular response to corticosterone stimulus(GO:0071386) |
3.8 | 15.3 | GO:1903576 | response to L-arginine(GO:1903576) |
3.8 | 30.4 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
3.8 | 22.8 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
3.8 | 127.6 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
3.7 | 48.7 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
3.7 | 37.0 | GO:0070995 | NADPH oxidation(GO:0070995) |
3.6 | 25.4 | GO:0000077 | DNA damage checkpoint(GO:0000077) |
3.6 | 25.3 | GO:0043486 | histone exchange(GO:0043486) |
3.6 | 21.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
3.4 | 31.0 | GO:0080009 | mRNA methylation(GO:0080009) |
3.4 | 13.7 | GO:0006004 | fucose metabolic process(GO:0006004) |
3.4 | 10.2 | GO:1905218 | cellular response to astaxanthin(GO:1905218) |
3.4 | 10.1 | GO:0045575 | basophil activation(GO:0045575) |
3.4 | 40.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
3.3 | 43.4 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
3.3 | 23.3 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
3.3 | 9.9 | GO:0072592 | oxygen metabolic process(GO:0072592) |
3.3 | 3.3 | GO:2000814 | positive regulation of barbed-end actin filament capping(GO:2000814) |
3.2 | 19.1 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
3.2 | 9.5 | GO:0060061 | regulation of collateral sprouting in absence of injury(GO:0048696) Spemann organizer formation(GO:0060061) canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
3.2 | 31.6 | GO:0014029 | neural crest formation(GO:0014029) |
3.2 | 25.3 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
3.1 | 47.1 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
3.1 | 9.4 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
3.1 | 12.5 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
3.1 | 34.1 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
3.1 | 12.3 | GO:0034240 | negative regulation of macrophage fusion(GO:0034240) |
3.1 | 9.3 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
3.1 | 18.4 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
3.1 | 39.9 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
3.1 | 36.7 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
3.0 | 9.1 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
3.0 | 33.5 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
3.0 | 9.0 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
3.0 | 12.0 | GO:0006517 | protein deglycosylation(GO:0006517) |
3.0 | 14.9 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
3.0 | 8.9 | GO:1902211 | regulation of prolactin signaling pathway(GO:1902211) |
3.0 | 8.9 | GO:0071895 | odontoblast differentiation(GO:0071895) |
2.9 | 8.8 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
2.9 | 35.3 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
2.9 | 8.8 | GO:0010265 | SCF complex assembly(GO:0010265) |
2.9 | 23.4 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
2.9 | 26.1 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
2.9 | 2.9 | GO:2001271 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
2.9 | 11.5 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
2.9 | 11.5 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
2.9 | 22.9 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
2.7 | 27.3 | GO:0018095 | protein polyglutamylation(GO:0018095) |
2.7 | 32.8 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
2.7 | 16.3 | GO:0046836 | glycolipid transport(GO:0046836) |
2.7 | 10.8 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
2.7 | 10.8 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
2.7 | 5.3 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
2.6 | 7.9 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
2.6 | 15.6 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
2.6 | 12.9 | GO:0032506 | cytokinetic process(GO:0032506) |
2.6 | 5.2 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) positive regulation of ubiquitin-specific protease activity(GO:2000158) |
2.5 | 7.6 | GO:0045337 | farnesyl diphosphate biosynthetic process(GO:0045337) |
2.5 | 290.7 | GO:0007059 | chromosome segregation(GO:0007059) |
2.5 | 5.0 | GO:0002476 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) |
2.5 | 7.6 | GO:0018992 | germ-line sex determination(GO:0018992) |
2.5 | 37.5 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
2.5 | 10.0 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
2.5 | 15.0 | GO:0070375 | ERK5 cascade(GO:0070375) |
2.5 | 32.4 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
2.5 | 2.5 | GO:0043578 | nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
2.5 | 4.9 | GO:1900175 | regulation of nodal signaling pathway involved in determination of left/right asymmetry(GO:1900145) regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900175) |
2.4 | 14.7 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
2.4 | 7.3 | GO:0010986 | regulation of high-density lipoprotein particle clearance(GO:0010982) positive regulation of lipoprotein particle clearance(GO:0010986) |
2.4 | 4.9 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
2.4 | 19.4 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
2.4 | 4.8 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
2.4 | 12.0 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
2.4 | 21.5 | GO:0000733 | DNA strand renaturation(GO:0000733) |
2.4 | 14.2 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
2.4 | 16.5 | GO:1904628 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
2.3 | 9.4 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
2.3 | 7.0 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
2.3 | 6.9 | GO:0072710 | response to hydroxyurea(GO:0072710) response to dithiothreitol(GO:0072720) |
2.3 | 13.9 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
2.3 | 36.6 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
2.3 | 4.6 | GO:0000448 | cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000448) |
2.2 | 15.7 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
2.2 | 15.7 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
2.2 | 11.1 | GO:0072366 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
2.2 | 17.7 | GO:0001842 | neural fold formation(GO:0001842) |
2.2 | 6.5 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
2.2 | 8.6 | GO:0048254 | snoRNA localization(GO:0048254) |
2.2 | 40.9 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
2.1 | 21.4 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
2.1 | 36.1 | GO:0070986 | left/right axis specification(GO:0070986) |
2.1 | 8.5 | GO:0010877 | lipid transport involved in lipid storage(GO:0010877) positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
2.1 | 12.6 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
2.1 | 10.4 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
2.1 | 16.5 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
2.0 | 188.3 | GO:0007050 | cell cycle arrest(GO:0007050) |
2.0 | 22.2 | GO:0051198 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
2.0 | 26.1 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
2.0 | 34.0 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
2.0 | 2.0 | GO:1904054 | regulation of cholangiocyte proliferation(GO:1904054) positive regulation of cholangiocyte proliferation(GO:1904056) cholangiocyte proliferation(GO:1990705) |
2.0 | 23.4 | GO:0019985 | translesion synthesis(GO:0019985) |
2.0 | 27.3 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
1.9 | 29.1 | GO:0051764 | actin crosslink formation(GO:0051764) |
1.9 | 11.6 | GO:0097338 | response to clozapine(GO:0097338) |
1.9 | 3.9 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
1.9 | 1.9 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
1.9 | 1.9 | GO:0046671 | negative regulation of retinal cell programmed cell death(GO:0046671) |
1.9 | 19.2 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
1.9 | 7.6 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
1.9 | 17.1 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
1.9 | 1.9 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
1.8 | 3.7 | GO:0000212 | meiotic spindle organization(GO:0000212) |
1.8 | 1.8 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
1.8 | 9.1 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
1.8 | 5.4 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
1.8 | 10.8 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
1.8 | 3.6 | GO:0097037 | heme export(GO:0097037) |
1.8 | 10.7 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
1.8 | 12.4 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
1.7 | 38.2 | GO:0048255 | mRNA stabilization(GO:0048255) |
1.7 | 12.2 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
1.7 | 20.5 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
1.7 | 13.7 | GO:1904869 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
1.7 | 66.2 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
1.7 | 21.6 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
1.6 | 26.4 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
1.6 | 1.6 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
1.6 | 19.6 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
1.6 | 11.4 | GO:0048496 | maintenance of organ identity(GO:0048496) |
1.6 | 6.4 | GO:0016240 | autophagosome docking(GO:0016240) |
1.6 | 11.2 | GO:1903826 | arginine transmembrane transport(GO:1903826) basic amino acid transmembrane transport(GO:1990822) |
1.6 | 11.2 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
1.6 | 9.6 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
1.6 | 4.7 | GO:0032978 | protein insertion into membrane from inner side(GO:0032978) |
1.6 | 11.0 | GO:0051013 | microtubule severing(GO:0051013) |
1.6 | 26.7 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
1.6 | 7.8 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
1.6 | 35.7 | GO:0050832 | defense response to fungus(GO:0050832) |
1.5 | 17.0 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
1.5 | 4.6 | GO:0031053 | primary miRNA processing(GO:0031053) |
1.5 | 4.6 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
1.5 | 7.5 | GO:0030070 | insulin processing(GO:0030070) |
1.5 | 10.4 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
1.5 | 5.9 | GO:0060631 | regulation of meiosis I(GO:0060631) |
1.5 | 11.8 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
1.5 | 10.2 | GO:1903376 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
1.4 | 13.0 | GO:0050779 | RNA destabilization(GO:0050779) |
1.4 | 15.9 | GO:0006013 | mannose metabolic process(GO:0006013) |
1.4 | 2.9 | GO:0099545 | trans-synaptic signaling by trans-synaptic complex(GO:0099545) |
1.4 | 5.8 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
1.4 | 21.6 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
1.4 | 14.4 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
1.4 | 10.0 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
1.4 | 4.3 | GO:0098507 | polynucleotide 5' dephosphorylation(GO:0098507) |
1.4 | 7.0 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
1.4 | 7.0 | GO:0061621 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
1.4 | 2.7 | GO:0010157 | response to chlorate(GO:0010157) |
1.4 | 17.7 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
1.4 | 44.6 | GO:0051290 | protein heterotetramerization(GO:0051290) |
1.3 | 4.0 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
1.3 | 46.9 | GO:0031047 | gene silencing by RNA(GO:0031047) |
1.3 | 16.0 | GO:0046605 | regulation of centrosome cycle(GO:0046605) |
1.3 | 10.6 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
1.3 | 21.2 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
1.3 | 35.4 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
1.3 | 5.2 | GO:1903564 | regulation of protein localization to cilium(GO:1903564) |
1.3 | 12.7 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
1.3 | 6.4 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
1.3 | 8.9 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
1.3 | 21.3 | GO:0019532 | oxalate transport(GO:0019532) |
1.3 | 6.3 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
1.2 | 11.2 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
1.2 | 24.6 | GO:0045116 | protein neddylation(GO:0045116) |
1.2 | 3.7 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
1.2 | 8.6 | GO:0043686 | co-translational protein modification(GO:0043686) |
1.2 | 7.3 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
1.2 | 2.4 | GO:0072553 | terminal button organization(GO:0072553) |
1.2 | 8.4 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
1.2 | 19.1 | GO:0006376 | mRNA splice site selection(GO:0006376) |
1.2 | 10.7 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
1.2 | 46.7 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
1.2 | 3.5 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
1.2 | 2.3 | GO:2000836 | positive regulation of androgen secretion(GO:2000836) |
1.1 | 3.4 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
1.1 | 31.5 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
1.1 | 6.7 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
1.1 | 5.4 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
1.1 | 2.1 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
1.1 | 19.3 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
1.1 | 8.5 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
1.1 | 8.5 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
1.1 | 6.3 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
1.1 | 8.4 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
1.0 | 9.2 | GO:0043249 | erythrocyte maturation(GO:0043249) |
1.0 | 6.1 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
1.0 | 3.1 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
1.0 | 7.1 | GO:0048664 | neuron fate determination(GO:0048664) |
1.0 | 12.2 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
1.0 | 19.3 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
1.0 | 1.9 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
1.0 | 5.8 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
1.0 | 4.8 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
1.0 | 6.7 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.9 | 0.9 | GO:2000040 | regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
0.9 | 12.2 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.9 | 6.5 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.9 | 3.7 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.9 | 6.5 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.9 | 9.3 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.9 | 7.4 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.9 | 2.7 | GO:0044752 | response to human chorionic gonadotropin(GO:0044752) |
0.9 | 5.4 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.9 | 3.6 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.9 | 22.6 | GO:0000154 | rRNA modification(GO:0000154) |
0.9 | 0.9 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.9 | 18.9 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.9 | 0.9 | GO:2000197 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.9 | 17.5 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.9 | 14.9 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.9 | 4.4 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.9 | 0.9 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
0.8 | 6.8 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.8 | 11.6 | GO:0051601 | exocyst localization(GO:0051601) |
0.8 | 34.8 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.8 | 8.9 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.8 | 3.2 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.8 | 1.6 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.8 | 10.3 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.8 | 3.9 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
0.8 | 4.7 | GO:0007099 | centriole replication(GO:0007099) |
0.8 | 13.9 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.8 | 1.5 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
0.7 | 0.7 | GO:0070370 | cellular heat acclimation(GO:0070370) |
0.7 | 11.9 | GO:0021854 | hypothalamus development(GO:0021854) |
0.7 | 11.8 | GO:0001675 | acrosome assembly(GO:0001675) |
0.7 | 5.9 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.7 | 3.7 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.7 | 15.9 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.7 | 6.5 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.7 | 1.4 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.7 | 5.7 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.7 | 5.7 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.7 | 2.8 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.7 | 4.2 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.7 | 1.4 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.7 | 1.4 | GO:0036337 | Fas signaling pathway(GO:0036337) |
0.7 | 5.5 | GO:0016556 | mRNA modification(GO:0016556) |
0.7 | 9.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.7 | 2.7 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.7 | 3.3 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.6 | 11.6 | GO:0035329 | hippo signaling(GO:0035329) |
0.6 | 3.8 | GO:0032392 | DNA geometric change(GO:0032392) |
0.6 | 8.9 | GO:0050927 | positive regulation of positive chemotaxis(GO:0050927) |
0.6 | 0.6 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.6 | 2.5 | GO:1904640 | response to methionine(GO:1904640) |
0.6 | 6.8 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.6 | 7.4 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.6 | 15.1 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.6 | 3.0 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.6 | 3.6 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.6 | 57.1 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
0.6 | 5.3 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.6 | 2.4 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.6 | 1.2 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.6 | 10.1 | GO:0010165 | response to X-ray(GO:0010165) |
0.6 | 3.5 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
0.6 | 29.0 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.6 | 1.2 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.6 | 6.8 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.6 | 5.0 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.6 | 10.0 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.6 | 2.2 | GO:0051444 | negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.5 | 10.9 | GO:0016445 | somatic diversification of immunoglobulins(GO:0016445) |
0.5 | 3.2 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.5 | 16.5 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.5 | 4.7 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.5 | 1.6 | GO:0006433 | prolyl-tRNA aminoacylation(GO:0006433) |
0.5 | 4.2 | GO:0006301 | postreplication repair(GO:0006301) |
0.5 | 9.4 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.5 | 6.9 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
0.5 | 2.9 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.5 | 8.8 | GO:0016180 | snRNA processing(GO:0016180) |
0.5 | 6.3 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
0.5 | 13.6 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.5 | 10.5 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.5 | 6.7 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.5 | 13.9 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
0.5 | 21.9 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
0.5 | 5.7 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.5 | 4.7 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.5 | 0.9 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.5 | 1.9 | GO:0006477 | protein sulfation(GO:0006477) |
0.5 | 11.6 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.5 | 13.6 | GO:0010833 | telomere maintenance via telomere lengthening(GO:0010833) |
0.5 | 16.8 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.4 | 1.3 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.4 | 1.3 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.4 | 3.1 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.4 | 70.0 | GO:0006281 | DNA repair(GO:0006281) |
0.4 | 12.5 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.4 | 1.3 | GO:0060290 | transdifferentiation(GO:0060290) |
0.4 | 2.1 | GO:0060014 | granulosa cell differentiation(GO:0060014) |
0.4 | 6.3 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.4 | 4.6 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.4 | 7.0 | GO:0051028 | mRNA transport(GO:0051028) |
0.4 | 7.4 | GO:0001502 | cartilage condensation(GO:0001502) |
0.4 | 16.4 | GO:0097006 | regulation of plasma lipoprotein particle levels(GO:0097006) |
0.4 | 3.6 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.4 | 44.5 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.4 | 1.9 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.4 | 2.2 | GO:0071569 | protein ufmylation(GO:0071569) |
0.4 | 3.3 | GO:0007512 | adult heart development(GO:0007512) |
0.4 | 64.9 | GO:0006397 | mRNA processing(GO:0006397) |
0.4 | 3.5 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.4 | 7.4 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.4 | 8.4 | GO:0030488 | tRNA methylation(GO:0030488) |
0.3 | 2.8 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.3 | 1.4 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.3 | 1.3 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.3 | 1.0 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.3 | 12.0 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.3 | 6.0 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.3 | 30.0 | GO:0007286 | spermatid development(GO:0007286) |
0.3 | 1.6 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.3 | 11.0 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.3 | 1.3 | GO:0030299 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
0.3 | 5.0 | GO:1903432 | regulation of TORC1 signaling(GO:1903432) |
0.3 | 4.6 | GO:0070897 | DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.3 | 1.5 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.3 | 1.1 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.3 | 1.1 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.3 | 3.4 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.3 | 2.0 | GO:0097068 | response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
0.3 | 4.4 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
0.3 | 3.3 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.3 | 2.2 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.3 | 3.0 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.3 | 12.8 | GO:0030317 | sperm motility(GO:0030317) |
0.3 | 1.6 | GO:0001783 | B cell apoptotic process(GO:0001783) |
0.3 | 0.8 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.3 | 6.0 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.3 | 2.5 | GO:0002021 | response to dietary excess(GO:0002021) |
0.2 | 5.9 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.2 | 0.2 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.2 | 0.5 | GO:0007127 | meiosis I(GO:0007127) |
0.2 | 1.2 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.2 | 0.2 | GO:0052490 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.2 | 3.6 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.2 | 0.7 | GO:0010266 | response to vitamin B1(GO:0010266) |
0.2 | 55.8 | GO:0000278 | mitotic cell cycle(GO:0000278) |
0.2 | 6.1 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.2 | 15.0 | GO:0030282 | bone mineralization(GO:0030282) |
0.2 | 2.5 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 1.4 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.2 | 14.6 | GO:0007030 | Golgi organization(GO:0007030) |
0.2 | 3.2 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.2 | 1.9 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.2 | 1.2 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.2 | 0.7 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.2 | 0.6 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.2 | 0.9 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) ornithine transport(GO:0015822) |
0.2 | 5.0 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.2 | 1.6 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.2 | 0.7 | GO:1904400 | response to Thyroid stimulating hormone(GO:1904400) cellular response to Thyroid stimulating hormone(GO:1904401) |
0.2 | 1.3 | GO:0090342 | regulation of cell aging(GO:0090342) |
0.2 | 5.8 | GO:0015914 | phospholipid transport(GO:0015914) |
0.1 | 10.2 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.1 | 1.8 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.1 | 0.4 | GO:0033306 | phytol metabolic process(GO:0033306) fatty alcohol metabolic process(GO:1903173) |
0.1 | 0.5 | GO:0070836 | caveola assembly(GO:0070836) |
0.1 | 7.2 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.1 | 1.6 | GO:0051225 | spindle assembly(GO:0051225) |
0.1 | 2.9 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.1 | 1.1 | GO:0002067 | glandular epithelial cell differentiation(GO:0002067) |
0.1 | 4.8 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 3.7 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 1.4 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 0.8 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.1 | 0.5 | GO:0002098 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) |
0.1 | 0.4 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.1 | 0.7 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 1.1 | GO:1900004 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 1.8 | GO:0001881 | receptor recycling(GO:0001881) |
0.1 | 0.2 | GO:0015811 | L-cystine transport(GO:0015811) |
0.1 | 7.7 | GO:0060271 | cilium morphogenesis(GO:0060271) |
0.1 | 0.5 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.0 | 0.4 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
0.0 | 0.7 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.0 | 2.1 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
0.0 | 0.2 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.1 | GO:0045076 | regulation of interleukin-2 biosynthetic process(GO:0045076) |
0.0 | 0.5 | GO:0032609 | interferon-gamma production(GO:0032609) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
79.4 | 317.8 | GO:0097149 | centralspindlin complex(GO:0097149) |
58.1 | 174.2 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
48.3 | 193.1 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
46.9 | 187.5 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
46.8 | 140.3 | GO:0097124 | cyclin A2-CDK2 complex(GO:0097124) |
37.3 | 3654.8 | GO:0000786 | nucleosome(GO:0000786) |
29.9 | 179.6 | GO:0032133 | chromosome passenger complex(GO:0032133) |
28.9 | 231.5 | GO:0000235 | astral microtubule(GO:0000235) aster(GO:0005818) |
26.6 | 186.3 | GO:0036449 | microtubule minus-end(GO:0036449) |
25.2 | 226.8 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
20.2 | 121.0 | GO:0071547 | piP-body(GO:0071547) |
19.0 | 19.0 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
18.7 | 18.7 | GO:1990826 | nucleoplasmic periphery of the nuclear pore complex(GO:1990826) |
17.5 | 52.4 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
16.7 | 83.7 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
14.7 | 44.2 | GO:1990423 | RZZ complex(GO:1990423) |
14.6 | 160.4 | GO:0042555 | MCM complex(GO:0042555) |
14.5 | 43.6 | GO:0000811 | GINS complex(GO:0000811) |
14.5 | 43.5 | GO:0033186 | CAF-1 complex(GO:0033186) |
14.4 | 28.8 | GO:0005713 | recombination nodule(GO:0005713) |
14.3 | 42.8 | GO:0044317 | rod spherule(GO:0044317) |
12.6 | 238.8 | GO:0010369 | chromocenter(GO:0010369) |
11.9 | 190.6 | GO:0042613 | MHC class II protein complex(GO:0042613) |
11.8 | 35.5 | GO:0031262 | Ndc80 complex(GO:0031262) |
10.9 | 43.5 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
10.6 | 31.7 | GO:0032301 | MutSalpha complex(GO:0032301) |
9.5 | 189.4 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
8.9 | 35.6 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
8.8 | 17.7 | GO:0071546 | pi-body(GO:0071546) |
8.3 | 33.1 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
8.2 | 74.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
8.1 | 120.9 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
8.0 | 56.3 | GO:0005828 | kinetochore microtubule(GO:0005828) |
7.6 | 60.9 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
7.6 | 53.0 | GO:0044815 | DNA packaging complex(GO:0044815) |
7.2 | 50.7 | GO:0042382 | paraspeckles(GO:0042382) |
7.1 | 262.4 | GO:0005876 | spindle microtubule(GO:0005876) |
7.0 | 674.3 | GO:0000776 | kinetochore(GO:0000776) |
7.0 | 13.9 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
7.0 | 13.9 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
6.9 | 20.7 | GO:0000802 | transverse filament(GO:0000802) |
6.9 | 158.2 | GO:0019013 | viral nucleocapsid(GO:0019013) |
6.7 | 47.1 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
6.6 | 39.8 | GO:0043203 | axon hillock(GO:0043203) |
6.5 | 19.5 | GO:0002945 | cyclin K-CDK12 complex(GO:0002944) cyclin K-CDK13 complex(GO:0002945) |
6.3 | 75.6 | GO:0000812 | Swr1 complex(GO:0000812) |
6.2 | 49.6 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
6.0 | 65.8 | GO:0097539 | ciliary transition fiber(GO:0097539) |
6.0 | 41.9 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
6.0 | 71.7 | GO:0072687 | meiotic spindle(GO:0072687) |
5.9 | 29.4 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
5.8 | 34.7 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
5.7 | 28.7 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
5.7 | 28.7 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
5.6 | 16.9 | GO:0032398 | MHC class Ib protein complex(GO:0032398) |
5.4 | 86.9 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
5.4 | 200.2 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
5.4 | 32.4 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
5.3 | 42.7 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
5.2 | 31.0 | GO:0036396 | MIS complex(GO:0036396) |
4.8 | 43.5 | GO:0097433 | dense body(GO:0097433) |
4.6 | 18.4 | GO:0099522 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
4.6 | 41.4 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
4.4 | 70.8 | GO:0033391 | chromatoid body(GO:0033391) |
4.4 | 39.7 | GO:0042405 | nuclear inclusion body(GO:0042405) |
4.3 | 21.8 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
4.3 | 30.2 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
4.2 | 37.4 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
4.1 | 20.5 | GO:0035189 | Rb-E2F complex(GO:0035189) |
4.1 | 180.7 | GO:0005657 | replication fork(GO:0005657) |
3.9 | 19.3 | GO:0071797 | LUBAC complex(GO:0071797) |
3.7 | 29.8 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
3.5 | 56.1 | GO:0070938 | contractile ring(GO:0070938) |
3.5 | 10.4 | GO:0032798 | Swi5-Sfr1 complex(GO:0032798) DNA recombinase mediator complex(GO:0033061) |
3.4 | 173.1 | GO:0072686 | mitotic spindle(GO:0072686) |
3.4 | 10.1 | GO:0035838 | growing cell tip(GO:0035838) |
3.3 | 13.4 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
3.1 | 15.5 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
3.1 | 24.7 | GO:0097443 | sorting endosome(GO:0097443) |
3.1 | 24.6 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
3.0 | 27.3 | GO:0070187 | telosome(GO:0070187) |
3.0 | 41.6 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
3.0 | 32.5 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
2.9 | 23.6 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
2.9 | 58.7 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
2.9 | 8.8 | GO:0046691 | intracellular canaliculus(GO:0046691) |
2.9 | 38.0 | GO:0032426 | stereocilium tip(GO:0032426) |
2.9 | 23.4 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
2.9 | 247.1 | GO:0000793 | condensed chromosome(GO:0000793) |
2.8 | 405.4 | GO:0044450 | microtubule organizing center part(GO:0044450) |
2.7 | 13.7 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
2.7 | 38.0 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
2.7 | 45.6 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
2.7 | 131.4 | GO:0005643 | nuclear pore(GO:0005643) |
2.7 | 21.4 | GO:0061700 | GATOR2 complex(GO:0061700) |
2.5 | 5.0 | GO:1990923 | PET complex(GO:1990923) |
2.4 | 55.4 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
2.4 | 14.3 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
2.3 | 21.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
2.3 | 11.7 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
2.3 | 25.6 | GO:0005682 | U5 snRNP(GO:0005682) |
2.3 | 34.8 | GO:0035102 | PRC1 complex(GO:0035102) |
2.3 | 4.6 | GO:0071141 | SMAD protein complex(GO:0071141) |
2.3 | 6.9 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
2.3 | 4.6 | GO:0032389 | MutLalpha complex(GO:0032389) |
2.3 | 6.9 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
2.2 | 251.6 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
2.2 | 39.2 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
2.2 | 26.0 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
2.1 | 14.7 | GO:0005687 | U4 snRNP(GO:0005687) |
2.1 | 16.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
2.1 | 8.3 | GO:0070876 | SOSS complex(GO:0070876) |
2.0 | 10.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
2.0 | 166.1 | GO:0016363 | nuclear matrix(GO:0016363) |
1.9 | 3.8 | GO:0035061 | interchromatin granule(GO:0035061) |
1.9 | 102.0 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
1.9 | 22.5 | GO:0001741 | XY body(GO:0001741) |
1.9 | 11.2 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
1.8 | 29.5 | GO:0000346 | transcription export complex(GO:0000346) |
1.8 | 77.0 | GO:0045171 | intercellular bridge(GO:0045171) |
1.8 | 23.7 | GO:0044666 | MLL3/4 complex(GO:0044666) |
1.8 | 12.7 | GO:0071203 | WASH complex(GO:0071203) |
1.8 | 21.6 | GO:0045120 | pronucleus(GO:0045120) |
1.8 | 8.9 | GO:0000322 | storage vacuole(GO:0000322) |
1.7 | 381.3 | GO:0000790 | nuclear chromatin(GO:0000790) |
1.7 | 44.6 | GO:0002080 | acrosomal membrane(GO:0002080) |
1.7 | 6.8 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
1.7 | 18.4 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
1.7 | 10.0 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
1.7 | 11.6 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.7 | 81.0 | GO:0005844 | polysome(GO:0005844) |
1.6 | 16.3 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
1.6 | 24.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
1.6 | 78.3 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
1.6 | 9.4 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
1.5 | 10.3 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
1.4 | 7.2 | GO:0097452 | GAIT complex(GO:0097452) |
1.4 | 20.1 | GO:0042611 | MHC protein complex(GO:0042611) |
1.4 | 22.9 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
1.4 | 8.6 | GO:0097422 | tubular endosome(GO:0097422) |
1.4 | 140.4 | GO:0005819 | spindle(GO:0005819) |
1.4 | 7.0 | GO:0000974 | Prp19 complex(GO:0000974) |
1.4 | 6.9 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
1.4 | 5.5 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
1.4 | 8.2 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
1.4 | 21.7 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
1.4 | 23.0 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
1.4 | 8.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
1.2 | 7.5 | GO:0036128 | CatSper complex(GO:0036128) |
1.2 | 11.1 | GO:0000124 | SAGA complex(GO:0000124) |
1.2 | 18.3 | GO:0032039 | integrator complex(GO:0032039) |
1.1 | 5.7 | GO:1990716 | axonemal central apparatus(GO:1990716) |
1.1 | 94.5 | GO:0000785 | chromatin(GO:0000785) |
1.1 | 2.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
1.1 | 3.3 | GO:0005688 | U6 snRNP(GO:0005688) |
1.1 | 3.3 | GO:0097651 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
1.1 | 75.8 | GO:0005694 | chromosome(GO:0005694) |
1.1 | 39.0 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
1.1 | 6.5 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
1.1 | 59.1 | GO:0016605 | PML body(GO:0016605) |
1.0 | 3.9 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
1.0 | 2.0 | GO:0060091 | kinocilium(GO:0060091) |
1.0 | 62.3 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
1.0 | 40.6 | GO:0016592 | mediator complex(GO:0016592) |
1.0 | 1.9 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.9 | 57.6 | GO:0036064 | ciliary basal body(GO:0036064) |
0.9 | 51.2 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.9 | 7.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.9 | 7.0 | GO:0031209 | SCAR complex(GO:0031209) |
0.9 | 27.0 | GO:0031941 | filamentous actin(GO:0031941) |
0.9 | 3.5 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.9 | 23.3 | GO:0032420 | stereocilium(GO:0032420) |
0.8 | 191.7 | GO:0016607 | nuclear speck(GO:0016607) |
0.8 | 2.5 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.8 | 3.3 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.8 | 9.0 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.8 | 20.2 | GO:0046930 | pore complex(GO:0046930) |
0.8 | 98.4 | GO:0005795 | Golgi stack(GO:0005795) |
0.8 | 0.8 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.8 | 7.0 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.8 | 6.8 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.7 | 20.0 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.7 | 1.5 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.7 | 12.1 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.7 | 11.2 | GO:0097449 | astrocyte projection(GO:0097449) |
0.7 | 1.4 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.7 | 4.7 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.7 | 4.6 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.6 | 1.9 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
0.6 | 3.9 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.6 | 1.8 | GO:0035577 | azurophil granule membrane(GO:0035577) tertiary granule membrane(GO:0070821) |
0.6 | 8.3 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.6 | 4.1 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.6 | 3.5 | GO:0034709 | methylosome(GO:0034709) |
0.6 | 3.5 | GO:0031415 | NatA complex(GO:0031415) |
0.5 | 33.0 | GO:0030496 | midbody(GO:0030496) |
0.5 | 5.5 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.5 | 3.2 | GO:0070652 | HAUS complex(GO:0070652) |
0.5 | 5.4 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.5 | 110.3 | GO:0031965 | nuclear membrane(GO:0031965) |
0.5 | 11.3 | GO:0042588 | zymogen granule(GO:0042588) |
0.5 | 2.9 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.5 | 11.9 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.5 | 2.8 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.4 | 1.3 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.4 | 3.5 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.4 | 4.6 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.4 | 1.2 | GO:1903349 | omegasome membrane(GO:1903349) omegasome(GO:1990462) |
0.4 | 1.6 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.4 | 21.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.4 | 3.3 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.3 | 6.9 | GO:0032040 | small-subunit processome(GO:0032040) |
0.3 | 1.0 | GO:0070545 | PeBoW complex(GO:0070545) |
0.3 | 6.5 | GO:0015030 | Cajal body(GO:0015030) |
0.3 | 6.0 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.3 | 39.3 | GO:0016604 | nuclear body(GO:0016604) |
0.2 | 19.7 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.2 | 2.6 | GO:0031519 | PcG protein complex(GO:0031519) |
0.2 | 19.9 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.2 | 6.6 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.2 | 5.6 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) |
0.2 | 4.5 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.2 | 5.6 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.2 | 2.5 | GO:0030904 | retromer complex(GO:0030904) |
0.2 | 5.3 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.2 | 10.4 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 1.6 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 11.1 | GO:0001650 | fibrillar center(GO:0001650) |
0.1 | 0.6 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
0.1 | 0.2 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.1 | 7.0 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 1.7 | GO:0005839 | proteasome core complex(GO:0005839) |
0.1 | 0.5 | GO:0033290 | eukaryotic 48S preinitiation complex(GO:0033290) |
0.1 | 0.2 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.1 | 0.5 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
64.0 | 255.9 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
46.9 | 187.5 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
45.3 | 181.4 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
39.4 | 157.7 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
32.8 | 164.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
30.8 | 277.1 | GO:0043515 | kinetochore binding(GO:0043515) |
24.6 | 73.8 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
15.3 | 61.3 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
13.4 | 66.8 | GO:0004104 | cholinesterase activity(GO:0004104) |
13.3 | 66.5 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
13.0 | 39.1 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
12.5 | 37.6 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
11.7 | 35.2 | GO:0031762 | follicle-stimulating hormone receptor binding(GO:0031762) |
11.4 | 68.4 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
11.2 | 56.2 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
11.1 | 22.1 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
10.8 | 53.8 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
10.1 | 40.2 | GO:0042610 | CD8 receptor binding(GO:0042610) |
9.5 | 66.7 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
9.5 | 38.0 | GO:0045159 | myosin II binding(GO:0045159) |
9.3 | 18.6 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
9.2 | 37.0 | GO:1990715 | mRNA CDS binding(GO:1990715) |
9.2 | 9.2 | GO:0008263 | pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263) |
8.8 | 52.6 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
8.4 | 234.6 | GO:0070840 | dynein complex binding(GO:0070840) |
8.3 | 33.1 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
8.2 | 131.8 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
8.1 | 40.6 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
8.1 | 40.6 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
8.0 | 217.3 | GO:0035173 | histone kinase activity(GO:0035173) |
7.9 | 47.5 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
7.9 | 39.4 | GO:0032357 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
7.8 | 31.3 | GO:0034584 | piRNA binding(GO:0034584) |
7.7 | 38.4 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
7.6 | 60.9 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
7.6 | 37.8 | GO:0032564 | dATP binding(GO:0032564) |
7.5 | 1424.3 | GO:0042393 | histone binding(GO:0042393) |
7.3 | 58.6 | GO:0030274 | LIM domain binding(GO:0030274) |
7.3 | 43.5 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
7.2 | 28.9 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
7.2 | 14.4 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
6.6 | 6.6 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) |
6.5 | 39.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
6.4 | 77.0 | GO:0003688 | DNA replication origin binding(GO:0003688) |
6.3 | 19.0 | GO:0008142 | oxysterol binding(GO:0008142) |
6.2 | 49.7 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
6.1 | 30.4 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
5.9 | 29.4 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
5.7 | 22.9 | GO:0050733 | RS domain binding(GO:0050733) |
5.6 | 22.4 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
5.6 | 33.5 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
5.6 | 22.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
5.6 | 389.3 | GO:0003777 | microtubule motor activity(GO:0003777) |
5.5 | 55.3 | GO:0042609 | CD4 receptor binding(GO:0042609) |
5.4 | 27.0 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
5.3 | 21.3 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
5.3 | 84.6 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
5.1 | 20.3 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
4.9 | 34.3 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
4.9 | 29.2 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
4.8 | 261.4 | GO:0031490 | chromatin DNA binding(GO:0031490) |
4.7 | 37.7 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
4.7 | 18.8 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
4.7 | 14.0 | GO:0050692 | DBD domain binding(GO:0050692) |
4.5 | 4.5 | GO:0032135 | DNA insertion or deletion binding(GO:0032135) |
4.4 | 39.7 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
4.4 | 17.4 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
4.3 | 107.9 | GO:0008536 | Ran GTPase binding(GO:0008536) |
4.3 | 51.5 | GO:0003678 | DNA helicase activity(GO:0003678) |
4.3 | 119.2 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
4.2 | 12.5 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
4.2 | 170.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
4.1 | 114.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
4.1 | 16.3 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
4.0 | 35.9 | GO:0008494 | translation activator activity(GO:0008494) |
4.0 | 11.9 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
3.9 | 31.4 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
3.9 | 46.6 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
3.8 | 11.3 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
3.7 | 37.4 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
3.7 | 22.0 | GO:0070878 | primary miRNA binding(GO:0070878) |
3.7 | 25.6 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
3.6 | 18.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
3.5 | 10.6 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
3.4 | 10.1 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
3.3 | 222.1 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
3.3 | 29.8 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
3.3 | 89.2 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
3.2 | 19.4 | GO:0070728 | leucine binding(GO:0070728) |
3.2 | 12.7 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
3.2 | 104.6 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
3.2 | 15.8 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
3.2 | 1898.4 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
3.2 | 123.2 | GO:0003684 | damaged DNA binding(GO:0003684) |
3.2 | 9.5 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
3.1 | 107.9 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
3.1 | 312.9 | GO:0017048 | Rho GTPase binding(GO:0017048) |
3.0 | 12.1 | GO:0016433 | rRNA (adenine) methyltransferase activity(GO:0016433) |
3.0 | 9.0 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
2.9 | 37.5 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
2.9 | 11.5 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
2.8 | 14.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
2.8 | 11.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
2.8 | 8.4 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
2.8 | 11.0 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
2.7 | 11.0 | GO:0030614 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
2.7 | 8.1 | GO:0004040 | amidase activity(GO:0004040) |
2.6 | 5.2 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
2.5 | 17.5 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
2.4 | 40.8 | GO:0097602 | cullin family protein binding(GO:0097602) |
2.4 | 23.6 | GO:0035198 | miRNA binding(GO:0035198) |
2.3 | 9.3 | GO:0035827 | rubidium ion transmembrane transporter activity(GO:0035827) |
2.2 | 38.1 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
2.2 | 126.1 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
2.2 | 10.8 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
2.2 | 8.6 | GO:0030622 | U4atac snRNA binding(GO:0030622) |
2.1 | 4.3 | GO:0004651 | polynucleotide 5'-phosphatase activity(GO:0004651) |
2.1 | 25.3 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
2.1 | 18.9 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
2.1 | 8.3 | GO:0061665 | SUMO ligase activity(GO:0061665) |
2.1 | 18.5 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
2.1 | 14.4 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
2.0 | 19.8 | GO:0045295 | gamma-catenin binding(GO:0045295) |
2.0 | 19.5 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
1.9 | 11.6 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
1.9 | 5.8 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) phosphopantetheine binding(GO:0031177) |
1.9 | 52.9 | GO:0003785 | actin monomer binding(GO:0003785) |
1.9 | 11.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
1.9 | 1.9 | GO:0016492 | G-protein coupled neurotensin receptor activity(GO:0016492) |
1.9 | 9.3 | GO:0001007 | transcription factor activity, RNA polymerase III transcription factor binding(GO:0001007) |
1.9 | 126.0 | GO:0070035 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
1.8 | 9.1 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
1.8 | 1.8 | GO:0070883 | pre-miRNA binding(GO:0070883) |
1.8 | 25.5 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
1.8 | 17.7 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
1.8 | 10.6 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
1.8 | 8.8 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
1.7 | 13.8 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
1.7 | 107.8 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
1.7 | 15.2 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
1.7 | 13.3 | GO:0009881 | photoreceptor activity(GO:0009881) |
1.7 | 11.6 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
1.6 | 4.9 | GO:0016015 | morphogen activity(GO:0016015) |
1.6 | 57.3 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
1.6 | 16.3 | GO:0016004 | phospholipase activator activity(GO:0016004) |
1.6 | 13.0 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
1.6 | 16.3 | GO:0070182 | DNA polymerase binding(GO:0070182) |
1.6 | 4.7 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
1.6 | 10.9 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
1.6 | 3.1 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
1.5 | 10.7 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
1.5 | 25.9 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
1.5 | 9.1 | GO:0016803 | ether hydrolase activity(GO:0016803) |
1.5 | 33.3 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
1.5 | 12.0 | GO:0004386 | helicase activity(GO:0004386) |
1.5 | 13.4 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
1.4 | 5.8 | GO:0030983 | mismatched DNA binding(GO:0030983) |
1.4 | 2.9 | GO:0004370 | glycerol kinase activity(GO:0004370) |
1.4 | 7.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
1.4 | 18.3 | GO:0070402 | NADPH binding(GO:0070402) |
1.4 | 21.0 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
1.4 | 11.2 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
1.4 | 6.9 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
1.4 | 23.3 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
1.4 | 472.0 | GO:0003682 | chromatin binding(GO:0003682) |
1.4 | 5.4 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
1.3 | 4.0 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
1.3 | 7.9 | GO:0008301 | DNA binding, bending(GO:0008301) |
1.3 | 9.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
1.3 | 26.2 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
1.3 | 51.1 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
1.3 | 10.3 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
1.3 | 7.7 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
1.3 | 43.5 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
1.2 | 3.7 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
1.2 | 30.8 | GO:0004707 | MAP kinase activity(GO:0004707) |
1.2 | 20.9 | GO:0015288 | porin activity(GO:0015288) |
1.2 | 7.3 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
1.2 | 14.6 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
1.2 | 27.9 | GO:0036002 | pre-mRNA binding(GO:0036002) |
1.2 | 7.3 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
1.2 | 4.8 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
1.2 | 35.2 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
1.2 | 37.5 | GO:0061733 | histone acetyltransferase activity(GO:0004402) peptide-lysine-N-acetyltransferase activity(GO:0061733) |
1.2 | 4.7 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
1.2 | 3.5 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
1.2 | 4.6 | GO:0004771 | sterol esterase activity(GO:0004771) |
1.1 | 14.6 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
1.1 | 44.3 | GO:0005484 | SNAP receptor activity(GO:0005484) |
1.1 | 19.3 | GO:0017091 | AU-rich element binding(GO:0017091) |
1.0 | 28.5 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
1.0 | 3.0 | GO:0008502 | melatonin receptor activity(GO:0008502) |
1.0 | 164.1 | GO:0008017 | microtubule binding(GO:0008017) |
1.0 | 19.0 | GO:0042288 | MHC class I protein binding(GO:0042288) |
1.0 | 15.9 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
1.0 | 2.9 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
1.0 | 10.6 | GO:0004532 | exoribonuclease activity(GO:0004532) |
1.0 | 3.8 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
1.0 | 87.2 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.9 | 2.8 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.9 | 3.7 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
0.9 | 4.6 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.9 | 15.4 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.9 | 12.5 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.9 | 2.7 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.9 | 345.8 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.9 | 118.4 | GO:0005516 | calmodulin binding(GO:0005516) |
0.8 | 61.1 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.8 | 3.3 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.8 | 13.0 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.8 | 2.4 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.8 | 15.2 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.8 | 42.7 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.8 | 3.1 | GO:0034046 | poly(G) binding(GO:0034046) |
0.8 | 11.7 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.8 | 28.7 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.8 | 6.1 | GO:0016936 | galactoside binding(GO:0016936) |
0.7 | 2.2 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.7 | 1.5 | GO:0042806 | fucose binding(GO:0042806) |
0.7 | 8.6 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.7 | 2.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.7 | 9.5 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.7 | 2.0 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.7 | 0.7 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.7 | 24.4 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.6 | 1.9 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
0.6 | 1.3 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.6 | 3.6 | GO:0031386 | protein tag(GO:0031386) |
0.6 | 4.7 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.6 | 4.6 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.6 | 1.7 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.6 | 10.3 | GO:0008199 | ferric iron binding(GO:0008199) |
0.6 | 3.4 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.6 | 2.2 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.6 | 5.5 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.6 | 3.3 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.5 | 2.7 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.5 | 5.3 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.5 | 1.6 | GO:0004827 | proline-tRNA ligase activity(GO:0004827) |
0.5 | 1.0 | GO:0047025 | 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity(GO:0047025) |
0.5 | 14.4 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.5 | 8.5 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.5 | 2.5 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.5 | 5.2 | GO:0004527 | exonuclease activity(GO:0004527) |
0.5 | 2.8 | GO:0070990 | snRNP binding(GO:0070990) |
0.4 | 5.4 | GO:0005521 | lamin binding(GO:0005521) |
0.4 | 3.1 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) |
0.4 | 4.0 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.4 | 0.9 | GO:0016429 | tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.4 | 2.2 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
0.4 | 1.2 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.4 | 5.4 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.4 | 15.1 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.4 | 63.5 | GO:0003729 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.4 | 3.6 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.4 | 1.2 | GO:0004918 | interleukin-8 receptor activity(GO:0004918) |
0.4 | 1.2 | GO:0019809 | spermidine binding(GO:0019809) |
0.4 | 1.2 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) TIR domain binding(GO:0070976) |
0.4 | 3.1 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.4 | 7.6 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.4 | 5.6 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.4 | 5.5 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.4 | 5.8 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.4 | 26.2 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.3 | 5.8 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.3 | 3.0 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.3 | 1.6 | GO:0004337 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
0.3 | 1.0 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.3 | 15.6 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.3 | 8.1 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.3 | 1.6 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.3 | 2.5 | GO:0008172 | S-methyltransferase activity(GO:0008172) cobalamin binding(GO:0031419) |
0.3 | 1.9 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.3 | 4.6 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.3 | 5.2 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.3 | 22.2 | GO:0000149 | SNARE binding(GO:0000149) |
0.3 | 25.8 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.3 | 4.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.3 | 9.3 | GO:0032934 | sterol binding(GO:0032934) |
0.3 | 5.0 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.3 | 1.4 | GO:0016505 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) peptidase activator activity involved in apoptotic process(GO:0016505) |
0.3 | 3.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.3 | 2.2 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.3 | 0.8 | GO:0002060 | purine nucleobase binding(GO:0002060) purine-nucleoside phosphorylase activity(GO:0004731) |
0.3 | 3.3 | GO:1902936 | phosphatidylinositol bisphosphate binding(GO:1902936) |
0.3 | 4.8 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.3 | 247.7 | GO:0003677 | DNA binding(GO:0003677) |
0.3 | 7.2 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.2 | 2.1 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.2 | 1.1 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.2 | 3.2 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.2 | 0.7 | GO:0004655 | porphobilinogen synthase activity(GO:0004655) |
0.2 | 0.4 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.2 | 17.3 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.2 | 8.5 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.2 | 1.6 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.2 | 10.1 | GO:0019003 | GDP binding(GO:0019003) |
0.2 | 1.6 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.2 | 0.9 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.2 | 2.5 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.2 | 3.3 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 0.9 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 4.3 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 0.4 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.1 | 133.1 | GO:0003723 | RNA binding(GO:0003723) |
0.1 | 0.8 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 4.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 15.4 | GO:0019887 | protein kinase regulator activity(GO:0019887) |
0.1 | 1.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 1.6 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.1 | 2.1 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.1 | 1.4 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.4 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 1.1 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.1 | 1.6 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.5 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.3 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 1.2 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 0.6 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.0 | 0.2 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.2 | GO:0010340 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.0 | 0.4 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 0.2 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.0 | 0.1 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
25.0 | 1223.1 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
16.5 | 842.3 | PID PLK1 PATHWAY | PLK1 signaling events |
8.3 | 415.9 | PID FANCONI PATHWAY | Fanconi anemia pathway |
8.1 | 105.8 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
7.0 | 245.8 | PID AURORA B PATHWAY | Aurora B signaling |
6.9 | 138.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
5.7 | 51.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
4.8 | 14.3 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
4.3 | 64.5 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
4.0 | 68.6 | PID ATR PATHWAY | ATR signaling pathway |
3.7 | 219.3 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
3.6 | 72.4 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
3.5 | 183.7 | PID E2F PATHWAY | E2F transcription factor network |
3.3 | 56.9 | PID BARD1 PATHWAY | BARD1 signaling events |
3.1 | 46.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
3.1 | 70.7 | PID ATM PATHWAY | ATM pathway |
2.5 | 20.3 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
2.5 | 45.0 | PID MYC PATHWAY | C-MYC pathway |
2.2 | 64.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
2.1 | 24.6 | PID AURORA A PATHWAY | Aurora A signaling |
2.0 | 95.3 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
1.8 | 7.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
1.7 | 31.4 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
1.7 | 8.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
1.7 | 50.1 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
1.5 | 29.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
1.5 | 16.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
1.4 | 37.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
1.4 | 69.1 | PID RHOA PATHWAY | RhoA signaling pathway |
1.3 | 35.1 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
1.3 | 20.5 | PID ARF 3PATHWAY | Arf1 pathway |
1.2 | 29.9 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
1.2 | 121.7 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
1.0 | 1.9 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
1.0 | 14.3 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.9 | 41.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.9 | 49.1 | PID CDC42 PATHWAY | CDC42 signaling events |
0.9 | 6.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.8 | 4.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.8 | 54.8 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.7 | 15.7 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.7 | 17.6 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.7 | 14.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.6 | 22.6 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.6 | 21.9 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.6 | 1.7 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.6 | 22.1 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.6 | 3.3 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.5 | 9.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.5 | 14.8 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.4 | 9.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.4 | 12.5 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.3 | 18.9 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.3 | 11.1 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 1.2 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.3 | 2.8 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.3 | 2.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 2.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.2 | 8.0 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 7.2 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.2 | 5.1 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.2 | 3.2 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.2 | 1.0 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.2 | 1.9 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.2 | 2.9 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.2 | 2.6 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 2.8 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 3.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 1.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 1.8 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.1 | 2.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 0.7 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 0.2 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 1.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 0.5 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.7 | PID IL1 PATHWAY | IL1-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
54.3 | 1410.6 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
25.7 | 410.7 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
23.9 | 262.7 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
16.7 | 399.8 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
16.5 | 181.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
14.4 | 158.3 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
13.9 | 319.8 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
12.0 | 372.8 | REACTOME KINESINS | Genes involved in Kinesins |
11.4 | 57.0 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
10.2 | 61.4 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
8.8 | 114.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
8.5 | 34.0 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
7.7 | 123.5 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
7.7 | 591.0 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
7.2 | 121.7 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
5.8 | 69.7 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
5.5 | 164.1 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
4.8 | 62.9 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
4.8 | 66.8 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
4.7 | 23.4 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
4.3 | 270.4 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
4.2 | 63.4 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
4.2 | 8.4 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
4.1 | 57.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
4.0 | 83.1 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
4.0 | 39.5 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
3.5 | 13.9 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
3.2 | 55.0 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
3.2 | 41.2 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
3.1 | 55.6 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
3.0 | 3.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
2.8 | 53.2 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
2.8 | 27.7 | REACTOME CHROMOSOME MAINTENANCE | Genes involved in Chromosome Maintenance |
2.7 | 57.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
2.6 | 20.8 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
2.6 | 23.3 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
2.6 | 61.5 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
2.5 | 50.1 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
2.4 | 234.2 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
1.9 | 18.6 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
1.8 | 51.6 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
1.8 | 34.3 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
1.7 | 21.0 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
1.7 | 36.9 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
1.6 | 24.6 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
1.6 | 21.3 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
1.5 | 22.9 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
1.5 | 19.8 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
1.5 | 30.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
1.5 | 54.6 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
1.4 | 33.2 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
1.4 | 68.9 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
1.4 | 53.0 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
1.3 | 20.1 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
1.2 | 24.7 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
1.1 | 20.3 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
1.1 | 19.2 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
1.0 | 23.0 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
1.0 | 4.8 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.9 | 10.4 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.9 | 8.2 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.9 | 43.4 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.8 | 129.9 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.8 | 94.2 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.8 | 22.0 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.8 | 39.9 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.8 | 6.4 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.8 | 13.2 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.8 | 6.9 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.8 | 26.6 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.7 | 8.8 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.7 | 8.7 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
0.7 | 2.7 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.6 | 15.7 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.6 | 1.8 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.6 | 6.6 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.6 | 30.9 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.6 | 8.3 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.6 | 5.7 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.6 | 9.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.6 | 55.6 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.5 | 5.7 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.4 | 13.5 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.4 | 4.1 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.4 | 3.2 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.4 | 6.9 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.4 | 11.2 | REACTOME GABA B RECEPTOR ACTIVATION | Genes involved in GABA B receptor activation |
0.4 | 6.0 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.4 | 3.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.3 | 6.4 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.3 | 0.6 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.3 | 4.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.3 | 6.2 | REACTOME GABA RECEPTOR ACTIVATION | Genes involved in GABA receptor activation |
0.3 | 8.9 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.2 | 30.7 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.2 | 2.7 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.2 | 2.4 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.2 | 4.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.2 | 2.6 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 2.5 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 1.8 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 1.1 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 1.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 2.2 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 1.2 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.1 | 1.5 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 2.1 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.1 | 0.6 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 3.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 1.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 1.1 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 2.5 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.5 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.4 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.2 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |